{"as_of":"2026-08-10T16:17:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:cd783564c3f39da2d37386f12b81d1d16af2207a8be1998c71e4422c5d640403","coverage":[{"denominator":98,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":98,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-08T20:18:10.067022Z","state":"measured"},{"denominator":100,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":100,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-10T06:31:04.303077+00:00","state":"measured"},{"denominator":2,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":2,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-05T20:46:50.282066Z","state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"arxiv_reference","source_observed_at":"2026-05-20T13:33:19.185960Z","state":"measured"}],"external_citation_measurements":[],"inbound":[{"citation":{"cited_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2502.05107","snapshot_observed_at":"2026-08-05T20:46:50.282066Z","title":"3dmolformer: A dual-channel framework for structure- based drug discovery","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2508.10075","last_updated":"2025-08-13T16:27:12Z","snapshot_observed_at":"2026-08-05T20:46:49.193471Z","submitted_at":"2025-08-13T16:27:12Z","title":"Teaching LLMs to Speak Spectroscopy","version":1},"reference_index":2021,"source":"pdf_text","source_observed_at":"2026-08-05T20:46:50.282066Z"},"links":{"cited_paper":"/paper/2502.05107","citing_paper":"/paper/2508.10075"},"observation_digest":"sha256:a8d9940480f6dfcca5ab9fbddd805dfd295813ae27782e9fb91a6a9128d5daa9","observation_id":"edee1cf9-9482-4d0d-af25-3cd725c0d2c8","resolution":{"observed_at":"2026-08-05T20:46:50.282066Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"cited_work":{"arxiv_id":"2502.05107","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2502.05107","snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"3dmolformer: A dual-channel framework for structure-based drug discovery.arXiv preprint arXiv:2502.05107, 2025a","venue":null,"work_id":"39b2f995-7a94-4590-9886-e3df4498fc26","year":null},"citing_paper":{"arxiv_id":"2605.17693","last_updated":"2026-05-17T23:21:24Z","snapshot_observed_at":"2026-08-02T07:03:49.160544Z","submitted_at":"2026-05-17T23:21:24Z","title":"Fine-tuning Pocket-Aware Diffusion Models via Denoising Policy Optimization","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-05-20T13:30:39.413079Z"},"links":{"cited_paper":"/paper/2502.05107","citing_paper":"/paper/2605.17693"},"observation_digest":"sha256:59671116e61fdea9d98a2b3d4615f38254a89543fec5d074c21d1ea790ae99b6","observation_id":"5769c0fc-f20c-4912-b018-2933ca97e332","resolution":{"observed_at":"2026-05-20T13:33:19.187671Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}}],"links":{"evidence":"/evidence","html":"/paper/2502.05107/citation-record","integrity":"/paper/2502.05107/integrity","json":"/paper/2502.05107/citation-record.json","paper":"/paper/2502.05107"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.713770Z","title":"write newline","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":1,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.713770Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:5b3ff653b9c2dd65beee566f16dc5e675d678f4724cb69e7420185775a09a6bd","observation_id":"cb4905a3-57a0-4074-97b9-d8ef266579a2","resolution":{"observed_at":"2026-08-08T20:18:09.713770Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.719484Z","title":"Accurate structure prediction of biomolecular interactions with alphafold 3","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":2,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.719484Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:189ae9d253fdaf745cb515091fb97e082fa040a2ba2329332e3311cb8c45c620","observation_id":"175415be-1ed1-4328-80c9-f563359d6ff1","resolution":{"observed_at":"2026-08-08T20:18:09.719484Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.723934Z","title":"Guiding deep molecular optimization with genetic exploration","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.723934Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3cd54231e1f2699261682d8a2e807db72df632b3359ef556cf8b504f9c6a3ea8","observation_id":"edb8bbf9-5717-4625-aaf6-edf06b42b52d","resolution":{"observed_at":"2026-08-08T20:18:09.723934Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2405.11769","last_updated":"2024-05-20T04:05:30Z","snapshot_observed_at":"2026-08-10T14:21:49.915356Z","submitted_at":"2024-05-20T04:05:30Z","title":"Uni-Mol Docking V2: Towards Realistic and Accurate Binding Pose Prediction","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2405.11769","snapshot_observed_at":"2026-08-08T20:18:09.728081Z","title":"Uni-mol docking v2: Towards realistic and accurate binding pose prediction","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":4,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.728081Z"},"links":{"cited_paper":"/paper/2405.11769","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:31ae8a0864f0860d73e9615944e66325f5a5be795148d727f5da68cd9e62f9b4","observation_id":"7914e2fb-fee1-4203-83bc-24e01fb905cc","resolution":{"observed_at":"2026-08-08T20:18:09.728081Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.732301Z","title":"Fast, accurate, and reliable molecular docking with quickvina 2","venue":null,"work_id":null,"year":2015},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":5,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.732301Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b823ff67d15f1d1abf54cd896d2cc8ea9d2517367181052575d01be6797b41e6","observation_id":"291a1c23-0e6a-48cb-bfaa-f6de406f7e3c","resolution":{"observed_at":"2026-08-08T20:18:09.732301Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.736088Z","title":"Randomized smiles strings improve the quality of molecular generative models","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":6,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.736088Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:8b9795bd4825ad8d10de1e9e0d9f34f1c4c513cae26fd65976a26f541d428bc0","observation_id":"84a79ba4-4014-4fc7-b53d-230ed3dd0ee0","resolution":{"observed_at":"2026-08-08T20:18:09.736088Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.739915Z","title":"Geometric deep learning on molecular representations","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":7,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.739915Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:1fbb987a317068a98c647edf37403e6da4ff79ab4ce5f9f7707bdb406baf0836","observation_id":"de7a1e2e-1604-4a21-a09c-a73e28c13d85","resolution":{"observed_at":"2026-08-08T20:18:09.739915Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.743673Z","title":"Accurate prediction of protein structures and interactions using a three-track neural network","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":8,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.743673Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:dafa8bd8a647f5f0c9775429182fe7af3a8323999f5535cfab947a35f35fccf8","observation_id":"f99b2367-86dc-4440-83bb-cd7a9ef8b88d","resolution":{"observed_at":"2026-08-08T20:18:09.743673Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.747136Z","title":"Molgpt: molecular generation using a transformer-decoder model","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":9,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.747136Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:36335f281162c9836628d81e64232e583aa7a0d9450847610f9fb4a44f3f3233","observation_id":"16f5c86c-0247-4e54-aab4-2923c667e32b","resolution":{"observed_at":"2026-08-08T20:18:09.747136Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.750930Z","title":"Can ai reproduce observed chemical diversity? bioRxiv, pp.\\ 292177, 2018","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":10,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.750930Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:78a03b01dc3b6560b81a84b027ace9b24d199425c96a66483a991927c874165d","observation_id":"c5cfb648-aa2f-4cdf-a9d9-14e668b21a26","resolution":{"observed_at":"2026-08-08T20:18:09.750930Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.755531Z","title":"Quantifying the chemical beauty of drugs","venue":null,"work_id":null,"year":2012},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.755531Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:52b14f3ec270d6441235350fb34330f8071547f9042fe959ce5001a114f5faa1","observation_id":"3a98d0e0-686d-48d9-bbc0-5a1f2ce727a2","resolution":{"observed_at":"2026-08-08T20:18:09.755531Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.758963Z","title":"The role of ai in drug discovery: challenges, opportunities, and strategies","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":12,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.758963Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:0dc83b30bcbc2af6a765a4b01b0275ccf58e20bbcdf05f6781b41099f18f2e72","observation_id":"0195aa7c-c8ea-4b7e-bb52-a4f0b401f557","resolution":{"observed_at":"2026-08-08T20:18:09.758963Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.762353Z","title":"Language models are few-shot learners","venue":null,"work_id":null,"year":1901},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":13,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.762353Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3be8183e96822a86a5f15f2cf128538e841a6c5bc463d0203beae330e821a48a","observation_id":"3c078ba4-f7c4-4f1c-8e4e-c1b301d9c225","resolution":{"observed_at":"2026-08-08T20:18:09.762353Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.765709Z","title":"Posebusters: Ai-based docking methods fail to generate physically valid poses or generalise to novel sequences","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":14,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.765709Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:cf4207294238d87f6f659e1eb7eb8581ac54710c8efddc80121a53170cbcc690","observation_id":"da742913-4ced-458c-b99e-165ea6c30eb0","resolution":{"observed_at":"2026-08-08T20:18:09.765709Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.769045Z","title":"Structure-aware protein self-supervised learning","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":15,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.769045Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a7abe8718b2b8d466d2016ca3cd9d04f4edcd012120e6101ecb3096c000fb81c","observation_id":"c87fed1c-8b61-4ab7-ad91-095ec8bffd93","resolution":{"observed_at":"2026-08-08T20:18:09.769045Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.772461Z","title":"Diffdock: Diffusion steps, twists, and turns for molecular docking","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":16,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.772461Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:130eb0f45f1ba6a40c27f824765bab9e7ba5bd4ce3ece37a2701e06b6ccc6030","observation_id":"f1900091-ff2a-4b90-bc04-ac9866934ade","resolution":{"observed_at":"2026-08-08T20:18:09.772461Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.775916Z","title":"Deep confident steps to new pockets: Strategies for docking generalization","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":17,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.775916Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:aaebd5c2c8750da1d5281700c998ad74ec82843a07f384078cc764ddcd5ae162","observation_id":"cd4b59d1-9e2c-4c39-8b30-7b5a6c3a7471","resolution":{"observed_at":"2026-08-08T20:18:09.775916Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.779115Z","title":"BERT : Pre-training of deep bidirectional transformers for language understanding","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":18,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.779115Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d44edab8d52595a253147fa03c33d11dbcae9047d698051313ac568ccbea24a6","observation_id":"443602cc-6519-47ec-9936-0ff20e35dd0b","resolution":{"observed_at":"2026-08-08T20:18:09.779115Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.782596Z","title":"Chai-1: Decoding the molecular interactions of life","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":19,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.782596Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:6cd5074e0d86bf2937158bef6c5916a3b88ba8297942993640f20a57ee0a9a0b","observation_id":"d4e31fac-3454-4608-8304-d998ac27c3dc","resolution":{"observed_at":"2026-08-08T20:18:09.782596Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2203.14500","last_updated":"2022-03-28T05:05:11Z","snapshot_observed_at":"2026-07-06T12:53:03.092529Z","submitted_at":"2022-03-28T05:05:11Z","title":"MolGenSurvey: A Systematic Survey in Machine Learning Models for Molecule Design","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2203.14500","snapshot_observed_at":"2026-08-08T20:18:09.785975Z","title":"Molgensurvey: A systematic survey in machine learning models for molecule design","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":20,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.785975Z"},"links":{"cited_paper":"/paper/2203.14500","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:db96417f002643114a353999228b047b9e706b5601a6e0858bf262df33536906","observation_id":"114b6848-860b-4014-9f3f-96ab0b27213d","resolution":{"observed_at":"2026-08-08T20:18:09.785975Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.267636Z","title":"Machine learning-aided generative molecular design","venue":null,"work_id":"7a6a22a0-9660-460e-91d4-8ad48e9cc135","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":21,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.789739Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b0ea05f80b448af96fcb882f8b7d7ee44249c821e550d9acb8d3bdaf020d0d72","observation_id":"5d0b6881-c3a5-46de-83e9-7405230c43c9","resolution":{"observed_at":"2026-08-08T20:18:11.271444Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.257313Z","title":"Autodock vina 1.2","venue":null,"work_id":"d1859a96-39d6-4417-9916-b00c996b11ba","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":22,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.793066Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a30173267d82c57b71e068e2aa17be69e2e7a108c2366212a0f6fa97eb40799a","observation_id":"8de2f3fa-9b0c-465c-9d21-f1a5e693dbfc","resolution":{"observed_at":"2026-08-08T20:18:11.260891Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.246299Z","title":"Limo: Latent inceptionism for targeted molecule generation","venue":null,"work_id":"dd4f6639-7699-4a41-b24a-36c513106ca7","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":23,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.796377Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:15758a5c6e8b9cd3054d14ca5e23414988fd5bc4059350f400e2274673d026ae","observation_id":"86b82672-5fb3-4160-bd6a-9125f66bd37f","resolution":{"observed_at":"2026-08-08T20:18:11.249951Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.235604Z","title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","venue":null,"work_id":"8a48110f-2743-420a-940b-c6adee634d64","year":2009},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":24,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.799823Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:12a240d79702aae806c9fbe0c3d9643815c48e63111c28b1163411f251545881","observation_id":"3d09dff8-68b6-4d4d-9cf2-16386eb4126b","resolution":{"observed_at":"2026-08-08T20:18:11.239402Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.224992Z","title":"Geometry-enhanced molecular representation learning for property prediction","venue":null,"work_id":"31bbd004-38e6-41b3-8762-97a31dd756d5","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":25,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.803086Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b56295d917a183ed20e2f4ee8d4669acbff1949a42a7bde10d3d8c5e15a389f9","observation_id":"e45490cd-a86b-41c7-9911-c6dbdc365b16","resolution":{"observed_at":"2026-08-08T20:18:11.228695Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.214555Z","title":"Protein-ligand binding representation learning from fine-grained interactions","venue":null,"work_id":"544dec3f-5f7e-4539-9c98-323ddb953d7b","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":26,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.806888Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:dfdae74610a2ac108c450de0b1c5f0c02dfdc7d2a6a88fefb020ebfed0f1a3cf","observation_id":"5134fab5-8ca1-4602-85f3-e040d6bb4a16","resolution":{"observed_at":"2026-08-08T20:18:11.218329Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.204140Z","title":"Generation of 3d molecules in pockets via a language model","venue":null,"work_id":"0496baea-be14-48c1-9eda-61baf49ec6b2","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":27,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.810512Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9c66f20c72e5aa6faec950cb3a8c430fc71809546fa2d5f86d140f217b3dcc6f","observation_id":"c9a6661d-0ef0-42b6-a6b0-d1bdbe464486","resolution":{"observed_at":"2026-08-08T20:18:11.207899Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2305.05708","last_updated":"2023-05-09T18:35:38Z","snapshot_observed_at":"2026-07-06T15:25:16.703799Z","submitted_at":"2023-05-09T18:35:38Z","title":"Language models can generate molecules, materials, and protein binding sites directly in three dimensions as XYZ, CIF, and PDB files","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2305.05708","snapshot_observed_at":"2026-08-08T20:18:09.813832Z","title":"Language models can generate molecules, materials, and protein binding sites directly in three dimensions as xyz, cif, and pdb files","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":28,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.813832Z"},"links":{"cited_paper":"/paper/2305.05708","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:26d927601c8a269277b1b9ae7f2cff5e239a2a5ad00e3754f98ad04a66104d02","observation_id":"167a9a6d-3db4-4bd0-82b4-31a7a5f1f8e1","resolution":{"observed_at":"2026-08-08T20:18:09.813832Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.194013Z","title":"Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design","venue":null,"work_id":"027cd0d4-82c2-4a1a-9453-6f0eeeeb686a","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":29,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.818243Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:8ded1481a5157852097b1c681e662395718d316f201dbb6e3d0c5b3466aee60b","observation_id":"6f22fe68-be67-4218-b169-34709dff0ddc","resolution":{"observed_at":"2026-08-08T20:18:11.197712Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.184198Z","title":"Reinforced genetic algorithm for structure-based drug design","venue":null,"work_id":"a4b012bd-130b-4d86-b8e1-7333b921b729","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":30,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.821781Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:72426d43e3c4149a44a3e1214b47ef3b5a8d5b7ef547f5ec83fee601f9053c5b","observation_id":"809debfa-a843-472c-b64f-a553d2b03b77","resolution":{"observed_at":"2026-08-08T20:18:11.187761Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.173724Z","title":"Drugclip: Contrasive protein-molecule representation learning for virtual screening","venue":null,"work_id":"caeae9a6-aab1-4b16-bd38-3b4ff771ad05","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":31,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.825199Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:73bf3a130ab12027ee70cdd8ed6c4f3367cf7cc7b82c8c38ed014168128e2c4a","observation_id":"3defdbf6-b430-439a-bad5-cf91c4e67438","resolution":{"observed_at":"2026-08-08T20:18:11.177401Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2403.12987","last_updated":"2024-03-04T07:40:25Z","snapshot_observed_at":"2026-07-06T17:47:13.814205Z","submitted_at":"2024-03-04T07:40:25Z","title":"Rethinking Specificity in SBDD: Leveraging Delta Score and Energy-Guided Diffusion","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2403.12987","snapshot_observed_at":"2026-08-08T20:18:09.829323Z","title":"Rethinking specificity in sbdd: Leveraging delta score and energy-guided diffusion","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":32,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.829323Z"},"links":{"cited_paper":"/paper/2403.12987","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:070c161dd959dfe3cb4d38e68cccbb68edffc71a69f03321223cc06a0e0188d0","observation_id":"aaa7dcaa-b49a-4f28-b0cf-fb0ba077fe92","resolution":{"observed_at":"2026-08-08T20:18:09.829323Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2310.02989","last_updated":"2024-12-15T07:07:28Z","snapshot_observed_at":"2026-08-02T07:22:00.304892Z","submitted_at":"2023-10-04T17:26:16Z","title":"xVal: A Continuous Numerical Tokenization for Scientific Language Models","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2310.02989","snapshot_observed_at":"2026-08-08T20:18:09.833094Z","title":"xval: A continuous number encoding for large language models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":33,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.833094Z"},"links":{"cited_paper":"/paper/2310.02989","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:829dd1742c50605e80f4ed13fe9a45778b4faaba135d192989f80dfdadab2e8a","observation_id":"c1b66612-293f-4725-a3a0-c623f770b23b","resolution":{"observed_at":"2026-08-08T20:18:09.833094Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.162985Z","title":"3d equivariant diffusion for target-aware molecule generation and affinity prediction","venue":null,"work_id":"ba961aa4-c64c-4fde-a0ed-74f391ff1754","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":34,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.836967Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9a0f56eee76a4f85dc83d95a015e69a194a2ac255f6339b6dc96eda2e16568f7","observation_id":"df18a194-d036-48bf-ab3b-a3710b7c5a16","resolution":{"observed_at":"2026-08-08T20:18:11.166691Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.152345Z","title":"Decompdiff: diffusion models with decomposed priors for structure-based drug design","venue":null,"work_id":"1bd0c90a-a1e5-41d9-ab25-24918a983dd6","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":35,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.840700Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:24412b38b84da13d28e25171da2c1897724f99f4f59684468d54c3a6a0edccd6","observation_id":"97e8ce77-4deb-492e-b50c-f47ffc221689","resolution":{"observed_at":"2026-08-08T20:18:11.156261Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2308.07413","last_updated":"2023-08-14T19:01:21Z","snapshot_observed_at":"2026-07-06T16:06:10.797909Z","submitted_at":"2023-08-14T19:01:21Z","title":"Benchmarking Generated Poses: How Rational is Structure-based Drug Design with Generative Models?","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2308.07413","snapshot_observed_at":"2026-08-08T20:18:09.844205Z","title":"Benchmarking generated poses: How rational is structure-based drug design with generative models? arXiv preprint arXiv:2308.07413, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":36,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.844205Z"},"links":{"cited_paper":"/paper/2308.07413","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:6a4edffe601f41754295ec7f72b56f025d9461cf0b7619723d2bc9d424dd9407","observation_id":"8fd3328e-c2fb-4094-ba7f-36942b62330d","resolution":{"observed_at":"2026-08-08T20:18:09.844205Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.141856Z","title":"De novo drug design using reinforcement learning with multiple gpt agents","venue":null,"work_id":"d2415303-6f7c-47cc-adbb-16bf908fe529","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":37,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.847898Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:cf5c472bd1eaa16176f94244efd36c2053294d9065d4d3c133a07f3dd76c6764","observation_id":"ce79d82f-a64d-46c2-abb2-89b79b6272c5","resolution":{"observed_at":"2026-08-08T20:18:11.145441Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.131302Z","title":"Hamiltonian diversity: effectively measuring molecular diversity by shortest hamiltonian circuits","venue":null,"work_id":"1034a288-ad2f-4a4a-aff0-c9bf805b3181","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":38,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.851141Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a7498b39a15e466b6d37ba07511811783a290939c6d58a8c7731dbb8cee4b102","observation_id":"0dda3e0d-3089-4e27-ba80-19b0fc6892ce","resolution":{"observed_at":"2026-08-08T20:18:11.134943Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.118924Z","title":"Chemformer: a pre-trained transformer for computational chemistry","venue":null,"work_id":"072801a0-e5fa-4940-a02f-9e7deed68605","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":39,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.854507Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:af4500cb14a874c1dc174cc28ca2fc31fa96e5df6308697a8f1844678a862242","observation_id":"33866d9d-7d99-455e-a563-02d86b0f8e2d","resolution":{"observed_at":"2026-08-08T20:18:11.123516Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.107054Z","title":"Structure-based drug design with geometric deep learning","venue":null,"work_id":"cc02509c-a239-41bb-8e50-ec9a0c2fa845","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":40,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.857785Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:1b9ab71bf0472056d7dc5aa7867d51d47ba0f06b29e2fef8bc64dc993af99693","observation_id":"1e8e51af-ebed-4a28-b6db-d670c9c6e887","resolution":{"observed_at":"2026-08-08T20:18:11.110962Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.095250Z","title":"Structure-based drug design with geometric deep learning","venue":null,"work_id":"1949994a-25cb-45cd-a641-828d8580ba4c","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":41,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.861275Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:be7c56e68d897c7b0573ab75848c5f44ec789f0b35baa77d63972aba17330dbd","observation_id":"a533c42a-2054-4750-b726-e7e76bf8ff21","resolution":{"observed_at":"2026-08-08T20:18:11.099207Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.082990Z","title":"Interactiongraphnet: A novel and efficient deep graph representation learning framework for accurate protein--ligand interaction predictions","venue":null,"work_id":"cc1db82b-f315-4fc4-86c2-5707aecada1e","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":42,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.864648Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fc22874ecebd9abe93aad52f7b28bd642c7cd3da90b7a2b413eefb7ae991bd5d","observation_id":"8cde88cd-2238-4928-ab7c-30a095cafe38","resolution":{"observed_at":"2026-08-08T20:18:11.086978Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.072362Z","title":"Jaakkola","venue":null,"work_id":"fb1a4e4d-fe9d-4af6-8e55-7608935597b0","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":43,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.868144Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7355f92ca22bea8c988203e04bcacff267a7cb418142ffd37e8af2ab14f441c1","observation_id":"2a893688-d5a5-470e-a489-63610d6bfc8f","resolution":{"observed_at":"2026-08-08T20:18:11.075979Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.061458Z","title":"Drugpose: benchmarking 3d generative methods for early stage drug discovery","venue":null,"work_id":"c48d5a6b-d7da-434d-9232-b5c78cc03037","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":44,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.871447Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f2cca0122c6a41fd7697e3a31cb10a0a17902b9f06aef0fd651430d2f94811ab","observation_id":"afca2a63-f09d-4378-b6fb-86783ebcf206","resolution":{"observed_at":"2026-08-08T20:18:11.065188Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.874810Z","title":"Highly accurate protein structure prediction with alphafold","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":45,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.874810Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f8215d75bf73329cbb59f165ac06d4045cfcc8e9321bb0691b6ef0319297b5ec","observation_id":"2363a87c-da66-4015-9263-667b839ba20b","resolution":{"observed_at":"2026-08-08T20:18:09.874810Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.878290Z","title":"On large-batch training for deep learning: Generalization gap and sharp minima","venue":null,"work_id":null,"year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":46,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.878290Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:68eccfaaf313ead03580e258b3dde9a42dae28b17f3de70874b6b2fec85fb4df","observation_id":"9796e93c-da49-4847-87e6-33ed677c9f1c","resolution":{"observed_at":"2026-08-08T20:18:09.878290Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.037137Z","title":"Lessons learned in empirical scoring with smina from the csar 2011 benchmarking exercise","venue":null,"work_id":"9b1cef30-cd20-41aa-8e4a-4a7bca2c814d","year":2011},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":47,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.881834Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b520f7f2e02288518cc00c0ce6490fce4b51f984a9c6c01f9e068a1b5ac8e627","observation_id":"26915f8d-e22a-4d62-872b-a4582757d782","resolution":{"observed_at":"2026-08-08T20:18:11.041335Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.025209Z","title":"Drug discovery with dynamic goal-aware fragments","venue":null,"work_id":"b190d5d0-bc33-4659-aef7-8d9d51c4a460","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":48,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.885478Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:8ebc7bb01d9d21a5276a71067e01f18e7d50bf764ddd115df8dbb413611548f1","observation_id":"80a50417-4fce-486f-9303-3b0ea3364f69","resolution":{"observed_at":"2026-08-08T20:18:11.029473Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.888887Z","title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":49,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.888887Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f59ae6726134ccb1adc4fab31ca74ba0251374eed773f6808d56752bd330a6f5","observation_id":"f3ee613f-7cfd-4405-89dc-2818fe8e34b8","resolution":{"observed_at":"2026-08-08T20:18:09.888887Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.005890Z","title":"Multi-objective reinforcement learning: A comprehensive overview","venue":null,"work_id":"92a5f080-cd0c-4b55-af7e-7d971fd5d1d8","year":2014},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":50,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.892177Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:c48227a4e4f9b3606b4f13bff7160300202c166c0288a26803aefc2df3e94d67","observation_id":"5871955d-c352-4df3-a203-3ec3ea0e425c","resolution":{"observed_at":"2026-08-08T20:18:11.009705Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.993693Z","title":"Generating 3d molecules for target protein binding","venue":null,"work_id":"4933ec77-c23e-4e0c-ab8d-6cd886f833e7","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":51,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.895610Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:04964821bc4aec82cf66b521080a58ef94c726ac8f0c2c0e42bc730f77359afd","observation_id":"2116e0f1-1dc4-4e7c-be56-7e2ad40b0c51","resolution":{"observed_at":"2026-08-08T20:18:10.998144Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.981817Z","title":"Forging the basis for developing protein--ligand interaction scoring functions","venue":null,"work_id":"4b164277-6136-48aa-a00d-c7a9c9b5f8c7","year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":52,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.899043Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:784ca70baad959328995e681ee033e8798e0af34d3f032f292548521c78e3638","observation_id":"c2f03439-4642-47b2-a3e4-2c92c6cd4747","resolution":{"observed_at":"2026-08-08T20:18:10.985874Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.969797Z","title":"Zero-shot 3d drug design by sketching and generating","venue":null,"work_id":"dc894bb9-afb2-4852-9a41-cc64cd7e1b73","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":53,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.902398Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:38a9579532c95b2a5ebfdec21942fdb8af5702a93c38448a4c69afbcd6ecb126","observation_id":"361f66e3-370a-476d-b533-8c41f2b90f5d","resolution":{"observed_at":"2026-08-08T20:18:10.973857Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.905762Z","title":"Decoupled weight decay regularization","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":54,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.905762Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9aafe7b7962e2a8b33921d7946a4d8271ecb0ae0ee6b649906337dd38906104e","observation_id":"82c39348-c42c-4a7f-8cf1-910c3e19d8f8","resolution":{"observed_at":"2026-08-08T20:18:09.905762Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.949320Z","title":"Tankbind: Trigonometry-aware neural networks for drug-protein binding structure prediction","venue":null,"work_id":"450099da-fc40-4c85-a179-a6531c251b2c","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":55,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.909234Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:354f2f038c3f690e12d19a65af75d2ffb0f4c3d11b9a15c7879069c141d691a7","observation_id":"fdfef723-b094-407e-a6b9-e8bc5a24395d","resolution":{"observed_at":"2026-08-08T20:18:10.953705Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.936591Z","title":"A 3d generative model for structure-based drug design","venue":null,"work_id":"852f2544-d15b-4e4c-be8c-93c3ad82ed3f","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":56,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.913235Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:32a820f0b2bdaaf348930585eb70735e097cb3497b9ae719f52e835548d2fff8","observation_id":"6c3db5b4-55b4-445c-9344-397370be813a","resolution":{"observed_at":"2026-08-08T20:18:10.940536Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.924488Z","title":"Artificial intelligence in drug discovery and development","venue":null,"work_id":"6ec65cd5-bc98-48c5-b6f6-a4e63b20051a","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":57,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.916506Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:135e2d963edf90c3c5ddf27a75ebc525644d31b8fbc55f12436716a81715d5cd","observation_id":"9c57cf47-f145-4284-874a-fa6356791452","resolution":{"observed_at":"2026-08-08T20:18:10.928459Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.912555Z","title":"A geometric deep learning approach to predict binding conformations of bioactive molecules","venue":null,"work_id":"c1b7c8cc-2fdd-4274-86eb-fc66fa83411c","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":58,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.919911Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:537f58723dcdbb0341a8b6a77075f3efa267100b6291b37e98e1486e8d43930e","observation_id":"3007bfd4-5740-42d0-b114-d49ef95813bd","resolution":{"observed_at":"2026-08-08T20:18:10.916486Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":"2405.14108","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.384141Z","title":"Deep learning for protein-ligand docking: Are we there yet? arXiv preprint arXiv:2405.14108, 2024","venue":null,"work_id":"58dbb235-75ac-4b27-9642-2ba4b6c7549b","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":59,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.923607Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:e4b7309118415f1f970dc13c7f737650c667ae619839018ab891adb742f11b4d","observation_id":"6a5def1d-2141-46cb-bfea-6c068a843d1e","resolution":{"observed_at":"2026-08-08T20:18:10.389782Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.900850Z","title":"Autodock4 and autodocktools4: Automated docking with selective receptor flexibility","venue":null,"work_id":"534e5a8d-fa4a-4b30-ab48-8229fecc43ee","year":2009},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":60,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.927002Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:109a1e527d80c5ff81b8c3b49b55bd0e1642325be25d00909223eba797f5e40c","observation_id":"66863145-1fb1-4bd3-b8ed-6b7302c1e708","resolution":{"observed_at":"2026-08-08T20:18:10.904723Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.930653Z","title":"Molecular de-novo design through deep reinforcement learning","venue":null,"work_id":null,"year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":61,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.930653Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:739d0e9161eb8d1980547f2bcbb32e7ec764aa69eb50bbb8d5a36c31cbad8e28","observation_id":"76b636e5-f07a-4e9d-b209-4da6de6850b7","resolution":{"observed_at":"2026-08-08T20:18:09.930653Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.880252Z","title":"Caught between a rock and a hard place: current challenges in structure-based drug design","venue":null,"work_id":"3698ff5e-71a2-44fe-9147-7dcdb85411a6","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":62,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.934017Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3cda85a7d0a003733cf07f8807e221c3e5bb09753227b9f38c41fc9b5c5a41bf","observation_id":"e475b478-ab33-4880-8879-9bffdcfb3ca1","resolution":{"observed_at":"2026-08-08T20:18:10.884189Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.867854Z","title":"Fabind: Fast and accurate protein-ligand binding","venue":null,"work_id":"ee028845-3173-43e5-b7f6-e101a69d69cb","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":63,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.937507Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:37bf13cc683620d9329b44bb15a5c5f2005cc31bbe5350bb35ea835e7e5167a0","observation_id":"509945b7-e991-4fc6-ba56-c718568433ce","resolution":{"observed_at":"2026-08-08T20:18:10.872277Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.855653Z","title":"Pocket2mol: Efficient molecular sampling based on 3d protein pockets","venue":null,"work_id":"845d7931-3509-4ddd-8072-ef35e3ae5fcf","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":64,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.940940Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:0dbfb6d95a39ab09f2173adac980ee256f51d2564e1e2325ecd0f339f6d1de73","observation_id":"2689b3dd-3284-482a-8f69-65a729c78977","resolution":{"observed_at":"2026-08-08T20:18:10.859832Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.843835Z","title":"Dive into deep learning: Tools for engagement","venue":null,"work_id":"7e2c8112-9976-4652-89e0-ecba6c5bd272","year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":65,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.944182Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4babdb0bbe8ac59d96efb9ed0fddbcd73997fd3bfad1c6758e77350774678b7a","observation_id":"6e74f67a-9406-405b-a7ab-e5b8baa79e57","resolution":{"observed_at":"2026-08-08T20:18:10.847934Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.831954Z","title":"Vinardo: A scoring function based on autodock vina improves scoring, docking, and virtual screening","venue":null,"work_id":"6be6c851-7364-45ce-b906-977230bc781e","year":2016},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":66,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.947483Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:54a52d4d2349eba77e92391ca31061150bd45c8eb651c4030f8c7e2d743f1934","observation_id":"87829da1-a78d-4ce6-9617-9e0d1451b83c","resolution":{"observed_at":"2026-08-08T20:18:10.836064Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.950978Z","title":"Language models are unsupervised multitask learners","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":67,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.950978Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:aa7b6cd435a9059b8b8fad8559971c22a9cf2ef2137d9cf12af3b986459756b5","observation_id":"679c2ab1-d598-46cb-b2c0-0a42de13ba4d","resolution":{"observed_at":"2026-08-08T20:18:09.950978Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.954278Z","title":"Generating 3d molecules conditional on receptor binding sites with deep generative models","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":68,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.954278Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7af983c85e12f4c9e42d17f8d9af46775b83c3b6ab628785788f24039f7ca238","observation_id":"70c3b1be-46ef-4ef3-a3c7-37c772cb17c1","resolution":{"observed_at":"2026-08-08T20:18:09.954278Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-08T05:39:11.029974Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-08T20:18:09.958049Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":69,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.958049Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:e72c60801b7d48535bde6228dccb6e8d15505b385c5a57a1d1a33c166f7eb0ac","observation_id":"346c372c-bac4-46a2-83e9-800f59cf6b2e","resolution":{"observed_at":"2026-08-08T20:18:09.958049Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.803693Z","title":"Molecular transformer: a model for uncertainty-calibrated chemical reaction prediction","venue":null,"work_id":"36835da0-cdea-4257-b465-aa420f53bf4f","year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":70,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.961908Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:091481fa73a68f9582d8e2c08d50458d1e35e9d4ccd92cabbcaa2ea32973f340","observation_id":"083e76c6-cee7-43ef-a572-734c0663562f","resolution":{"observed_at":"2026-08-08T20:18:10.807910Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.792076Z","title":"Generating focused molecule libraries for drug discovery with recurrent neural networks","venue":null,"work_id":"3506e3f4-1498-40d8-825d-3dc8db59fcaf","year":2018},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":71,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.965288Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:6d3b298f05de3f62c2b46179c53388c7b081f58bb804651a2ec5a5470274a3b6","observation_id":"8fb21802-63b4-4198-be83-2c971f26bf4b","resolution":{"observed_at":"2026-08-08T20:18:10.795986Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.780230Z","title":"Reinforcement learning for molecular design guided by quantum mechanics","venue":null,"work_id":"c1e04c99-8a6b-405a-9563-98a8857b909d","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":72,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.968510Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:59278f7bcefd7b4e7e409027774b992a2f4c635620eacfce4a3e46ec2f992ee1","observation_id":"8bf760f4-8384-4a1e-ab5f-1f729ee2e336","resolution":{"observed_at":"2026-08-08T20:18:10.784295Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.768680Z","title":"Autogrow4: an open-source genetic algorithm for de novo drug design and lead optimization","venue":null,"work_id":"4674081c-5a55-493f-b59f-c13534cb92f0","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":73,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.971671Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:e845a26e9134212ea276d6ebd525ac05e3a03f6306efb324e4f49d062aaf6647","observation_id":"264d2119-d088-46b9-bbf5-42403ee00777","resolution":{"observed_at":"2026-08-08T20:18:10.772677Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.758104Z","title":"Equibind: Geometric deep learning for drug binding structure prediction","venue":null,"work_id":"b07fbd31-6acd-4e5d-85fe-b1918b905da0","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":74,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.975113Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ca85ea5130178a29a31deed797bb40c58494f8a7b4b8be7f4b38a70f60b69837","observation_id":"bedc8dbb-5bbe-445c-8453-608ddb6f3e95","resolution":{"observed_at":"2026-08-08T20:18:10.761845Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.637027Z","title":"Comparative assessment of scoring functions: the casf-2016 update","venue":null,"work_id":"da64dca0-025b-4e5d-8040-67e21d49b71d","year":2016},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":75,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.979039Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:32159776b8d59072ef6334a9090826335ef469bc9753b188f9781e747febd994","observation_id":"a4bec532-85d6-4ccf-9691-4faa636b3420","resolution":{"observed_at":"2026-08-08T20:18:10.751038Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2303.17615","last_updated":"2024-01-30T21:09:48Z","snapshot_observed_at":"2026-08-09T05:02:17.368406Z","submitted_at":"2023-03-30T07:40:50Z","title":"Utilizing Reinforcement Learning for de novo Drug Design","version":2},"cited_work":{"arxiv_id":"2303.17615","doi":null,"metadata_source":"pith","pith_arxiv_id":"2303.17615","snapshot_observed_at":"2026-08-08T20:18:10.170252Z","title":"Utilizing Reinforcement Learning for de novo Drug Design","venue":"q-bio.BM","work_id":"0c8efddd-e310-42c2-b115-6e58336429c0","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":76,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.982465Z"},"links":{"cited_paper":"/paper/2303.17615","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d441470ee874d949829797fd9e5b8a7b79c81c4b641d2942aa476d6e75d9b39c","observation_id":"d323661d-bb53-43a3-9a4c-496702d57ffa","resolution":{"observed_at":"2026-08-08T20:18:10.174588Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.626865Z","title":"Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","venue":null,"work_id":"33ad1a6d-05ed-4229-b423-9c4f92df9f95","year":2010},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":77,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.986290Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:37dc1a42facff621d7511f09d58459286247fa66e1f1270bc71ced4917438f9c","observation_id":"0575cba2-2027-4bbd-ab31-f790cb65da9f","resolution":{"observed_at":"2026-08-08T20:18:10.630691Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.616682Z","title":"Structure-based drug design: aiming for a perfect fit","venue":null,"work_id":"4eb7d928-5d6a-4854-baa6-a4e5881914c6","year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":78,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.989810Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d430b5f99a9b2fe4122d6bbb14206b719420a72ed6d8714f59b35b7ec236ee2f","observation_id":"aeea9409-18e7-4af4-8dbe-bae6659c9b66","resolution":{"observed_at":"2026-08-08T20:18:10.620494Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.604499Z","title":"Structure-based, deep-learning models for protein-ligand binding affinity prediction","venue":null,"work_id":"1ace244f-cc5a-44e5-8cd1-1468de494920","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":79,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.993216Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:5c0549c371db9b1f1bc43451a54c2cfa61a467c6dfcaad72ba4f76f63e09e9e0","observation_id":"8282e32b-1ac5-4642-98ba-0bd70f49ce4f","resolution":{"observed_at":"2026-08-08T20:18:10.608387Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2407.07930","last_updated":"2024-08-19T07:32:25Z","snapshot_observed_at":"2026-07-06T18:44:24.873040Z","submitted_at":"2024-07-10T07:22:15Z","title":"Token-Mol 1.0: Tokenized drug design with large language model","version":2},"cited_work":{"arxiv_id":"2407.07930","doi":null,"metadata_source":"pith","pith_arxiv_id":"2407.07930","snapshot_observed_at":"2026-08-08T20:18:10.155644Z","title":"Token-Mol 1.0: Tokenized drug design with large language model","venue":"q-bio.BM","work_id":"dad34a0a-b5e2-4fd6-86ab-1b43c500ff65","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":80,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.996703Z"},"links":{"cited_paper":"/paper/2407.07930","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f8b151c71a4cdd9cb0a0a657a6e14869f351376226620942ef189e4cc9ea1f21","observation_id":"a687610c-4b0e-4367-a834-54241b5d3cc6","resolution":{"observed_at":"2026-08-08T20:18:10.159700Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.593365Z","title":"Property-aware relation networks for few-shot molecular property prediction","venue":null,"work_id":"21deebdd-220a-4df5-99c0-2ee53a43c0e1","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":81,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.000112Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b60179449c8b70c2c56b7a3d8344c2fd62dc52b7d00ad8d275d0ecf4da20c75c","observation_id":"c6159adf-f65a-4b11-a9af-1534ddfc9508","resolution":{"observed_at":"2026-08-08T20:18:10.597186Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.581601Z","title":"A compact review of molecular property prediction with graph neural networks","venue":null,"work_id":"73e4e931-f27f-4b8b-bbf2-c2439d8952c7","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":82,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.003437Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f03197a14075b6a498c6193894e684175eab76a06df36a2271ad85a52902a8bb","observation_id":"c2f57260-5437-4b27-9d2c-a8c8a31433bc","resolution":{"observed_at":"2026-08-08T20:18:10.585914Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.569375Z","title":"A systematic survey of chemical pre-trained models","venue":null,"work_id":"2e6848f1-2ade-444e-ae6c-83f016447a2f","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":83,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.007159Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f0ce8281ed3384a79787c677ceb34ca7d54d6b803c1d86c6b7de506a87888cba","observation_id":"ffb26cbd-246e-41ca-8421-eab55dda90d3","resolution":{"observed_at":"2026-08-08T20:18:10.573497Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.558677Z","title":"Protein--ligand docking in the machine-learning era","venue":null,"work_id":"ae91b17d-ac0a-46b1-b270-3e527f3695e9","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":84,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.010547Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9bc5de1683c8d52910131591687a9c1dc56382a0bbe77ef1479e8bb3a90d6df8","observation_id":"4c70bd3f-93b0-4375-a015-94504c190966","resolution":{"observed_at":"2026-08-08T20:18:10.562494Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.548507Z","title":"Deep molecular representation learning via fusing physical and chemical information","venue":null,"work_id":"ee250599-d8f4-4488-9e08-42ce92b20eca","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":85,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.013813Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4d016191acee5c95a555e23dab64c9c9251afecee7b37f506c8ca9ccc06d52ad","observation_id":"04b8d631-320f-4842-af32-b6cbd7e112d6","resolution":{"observed_at":"2026-08-08T20:18:10.552259Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.538401Z","title":"Hit and lead discovery with explorative rl and fragment-based molecule generation","venue":null,"work_id":"a581fc0d-b55f-4129-a27f-9bf658481119","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":86,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.017199Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d3fe99dcd428aed4b31e6da1802f8ed17d26ef54d2b27a1d09adf6bef293dd8e","observation_id":"946711d7-4f20-48e8-8f32-50cb6888ed0a","resolution":{"observed_at":"2026-08-08T20:18:10.542025Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.527507Z","title":"Graph convolutional policy network for goal-directed molecular graph generation","venue":null,"work_id":"f9939f94-c8fd-479f-b1dc-3f58e672bc47","year":2018},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":87,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.021340Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:571b180858281279771394e8557394572ebe00493b6322ad1ec95a8f6e5fd133","observation_id":"abbb046f-71c2-487e-92ed-cc2607b874df","resolution":{"observed_at":"2026-08-08T20:18:10.531423Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.515994Z","title":"E3bind: An end-to-end equivariant network for protein-ligand docking","venue":null,"work_id":"71b1c7b1-729e-414f-8f92-ebd656974c07","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":88,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.025782Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:00b30fa40b9b1375bbd70d92aba4dc69c31f7c7c353b7f2f2e09a05295fe9eca","observation_id":"f8a7be81-e268-4b2f-9f01-068283e9c104","resolution":{"observed_at":"2026-08-08T20:18:10.519706Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.504808Z","title":"Motif-based graph self-supervised learning for molecular property prediction","venue":null,"work_id":"908b12f8-2191-460a-bf6a-24282179fe28","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":89,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.029168Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:27a1912d4eb1e750fcb478fb47aafdf58a919d609b6d4be5862e88a1bad9982e","observation_id":"38aed36c-c43d-47be-b181-4362b8ea15c9","resolution":{"observed_at":"2026-08-08T20:18:10.508510Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2306.11768","last_updated":"2024-11-16T02:51:56Z","snapshot_observed_at":"2026-08-07T07:32:13.836485Z","submitted_at":"2023-06-20T14:21:58Z","title":"Geometric Deep Learning for Structure-Based Drug Design: A Survey","version":6},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2306.11768","snapshot_observed_at":"2026-08-08T20:18:10.033108Z","title":"A systematic survey in geometric deep learning for structure-based drug design","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":90,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.033108Z"},"links":{"cited_paper":"/paper/2306.11768","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fb211ebe59dfeb903d90759a341a91cbbbaa2885e86504a085e435004dfc77e0","observation_id":"3fbfe4f9-2f6c-4fea-a03e-c731182e6481","resolution":{"observed_at":"2026-08-08T20:18:10.033108Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.493919Z","title":"A brief review of protein--ligand interaction prediction","venue":null,"work_id":"f01fbf71-ee61-4021-9072-4c1e5bae5531","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":91,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.037090Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7d2a8c09b9b9d0e14fa7570aefb7fb615f349d80bd9e57827523cc83c694f144","observation_id":"a153ff62-f977-41ae-8177-a77c7469c97f","resolution":{"observed_at":"2026-08-08T20:18:10.497904Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2406.03403","last_updated":"2024-06-04T15:37:14Z","snapshot_observed_at":"2026-08-10T14:06:11.753552Z","submitted_at":"2024-06-04T15:37:14Z","title":"Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?","version":1},"cited_work":{"arxiv_id":"2406.03403","doi":null,"metadata_source":"pith","pith_arxiv_id":"2406.03403","snapshot_observed_at":"2026-08-08T20:18:10.130525Z","title":"Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?","venue":"cs.LG","work_id":"b0410432-ce9b-436a-a78d-b85f480cb448","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":92,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.040546Z"},"links":{"cited_paper":"/paper/2406.03403","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3b3bca5924a872ae022d5dcca2f2564fcfc010e99ffc2a29315e054aa4b6c3fc","observation_id":"2743eae0-ad14-4ccf-9056-e858260bc2a7","resolution":{"observed_at":"2026-08-08T20:18:10.134374Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.483004Z","title":"Uni-mol: A universal 3d molecular representation learning framework","venue":null,"work_id":"87937cf1-7516-454d-9a48-33065f795949","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":94,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.048412Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:e8fd58bec84060d2af6390730af76324bb9dc6b148f50057f5cedd972237cd00","observation_id":"5312db31-4ac8-4ba0-ace7-8ff9963bfc64","resolution":{"observed_at":"2026-08-08T20:18:10.486834Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2302.07061","last_updated":"2023-03-27T14:15:37Z","snapshot_observed_at":"2026-07-06T14:51:40.948938Z","submitted_at":"2023-02-14T14:21:26Z","title":"Do Deep Learning Methods Really Perform Better in Molecular Conformation Generation?","version":2},"cited_work":{"arxiv_id":"2302.07061","doi":null,"metadata_source":"pith","pith_arxiv_id":"2302.07061","snapshot_observed_at":"2026-08-08T20:18:10.100544Z","title":"Do Deep Learning Methods Really Perform Better in Molecular Conformation Generation?","venue":"cs.CE","work_id":"b11d2e21-d53a-48fc-9a66-707bbc0d2fbc","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":95,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.051779Z"},"links":{"cited_paper":"/paper/2302.07061","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:92914506894a2200cfc8a57c8e300743abbbdacc444839bc5ed296878d1d0bb8","observation_id":"bf3fe4c2-9dd4-4934-bc0c-de25d23ec97e","resolution":{"observed_at":"2026-08-08T20:18:10.107568Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.472111Z","title":"Unified 2d and 3d pre-training of molecular representations","venue":null,"work_id":"3e81b2d9-99c0-4f58-a169-31702801aad5","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":96,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.055502Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:cc1d188ed047d7fa70af2abdecb3ead18af67d367fa5d0610de31079e27daa9a","observation_id":"ba3de2d3-1021-47b8-bbe8-9ea6c81fadb7","resolution":{"observed_at":"2026-08-08T20:18:10.475868Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.059028Z","title":"@esa (Ref","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":97,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.059028Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:8bd08fc25e6f9df7a545bc249ab763b2655a96d07e1711960568b26e9780f76c","observation_id":"addbffc9-7b7e-440d-9048-d8ba6c465dbd","resolution":{"observed_at":"2026-08-08T20:18:10.059028Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.063098Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":98,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.063098Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4558407031dcffe5c272621fb541faf077322d8343ec5af50f4def36fa42a747","observation_id":"be63a7fa-2cf3-4ab9-891c-85ba162f80ec","resolution":{"observed_at":"2026-08-08T20:18:10.063098Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2406.03686","last_updated":"2024-06-06T02:10:50Z","snapshot_observed_at":"2026-07-06T18:26:15.151211Z","submitted_at":"2024-06-06T02:10:50Z","title":"BindGPT: A Scalable Framework for 3D Molecular Design via Language Modeling and Reinforcement Learning","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2406.03686","snapshot_observed_at":"2026-08-08T20:18:10.067022Z","title":"BERT : Pre-training of Deep Bidirectional Transformers for Language Understanding","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":99,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.067022Z"},"links":{"cited_paper":"/paper/2406.03686","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ee21e6dc715c09c89fc01da2fab8a0187599e8853e553f13ffa0c14b34c073f7","observation_id":"1bb5577f-c904-41b3-9254-4f8905188f85","resolution":{"observed_at":"2026-08-08T20:18:10.067022Z","resolver_source":null,"status":"malformed_identifier"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","latest_version":1,"primary_category":"cs.CE","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery"},"reference_resolution":{"displayed":98,"state_counts":{"malformed_identifier":1,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":35,"verified_exact":5,"verified_fuzzy":57},"total_outbound_references":98},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"thesis":"As of 10 August 2026, this Paper Citation Record lists 98 of 98 outbound references and 2 inbound Pith citation observations for arXiv:2502.05107."}